Nanoscope Therapeutics Reports P-IIb Trial (RESTORE) Results of MCO-010 for the Treatment of Retinitis Pigmentosa
Shots: The P-IIb trial evaluating MCO-010 (IVT) vs PBO in 27 patients showed visio...
Takeda Published P-IV Study (EARNEST) Results of Vedolizumab for Chronic Pouchitis in NEJM
Shots: The P-IV study (EARNEST) evaluating vedolizumab vs PBO in patients who had...
Janssen Reports P-I Study (CHRYSALIS) Results of Rybrevant (amivantamab-vmjw) for Advanced Non-Small Cell Lung Cancer with EGFR Ex...
Shots: The P-I study evaluates Rybrevant as a monotx. and in combination with Laze...
Affimed Reports First Patient Dosing of AFM28 in the P-I Study for the Treatment of CD123-Positive Acute Myeloid Leukemia
Shots: The first patient has been dosed in a P-I open-label, first-in-human dose e...
Shanghai Henlius Biotech Reports the First Patient Dosing of HLX15 (biosimilar, daratumumab) in P-I Clinical Trial for Multiple My...
Shots: The first patient has been dosed in the P-I trial that consists of 2 parts...
Zealand Pharma Reports Results from P-Ia Study of ZP8396 for Patients with Obesity and Diabetes
Shots: Results showed a reduction in body weight of up to a mean of 4.2% from base...
